33.90SEK-1.45%Mkt Cap: 1.12B SEKP/E: 38.64Last update: 2026-05-13
C-Rad AB (publ) develops, manufactures, and sells products and systems with applications in radiotherapy for the treatment of cancer in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company off…
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)38.64
P/E (Forward)15.04
PEG—
P/B3.31
P/S2.62
EV/EBITDA16.66
EV/Revenue2.40
EPS (TTM)0.88
EPS (Forward)2.26
Cash Flow & Leverage
FCF Yield-0.32%
FCF Margin-0.83%
Operating CF71.08M SEK
CapEx (TTM)20.78M SEK
Net Debt/EBITDA-2.04
Net Debt-125.80M SEK
Technical
SMA 5027.29 (+24.2%)
SMA 20030.70 (+10.4%)
Beta—
S&P 52W Chg24.23%
Avg Vol (30d)25.67K
Avg Vol (10d)54.15K
Technical Indicators
RSI (14)74.5
MACD1.8267
MACD Signal0.9643
MACD Hist.+0.8624
BB Upper35.43 SEK
BB Middle28.75 SEK
BB Lower22.08 SEK
BB Width46.41%
ATR (14)1.381 SEK
Vol Ratio (20d)0.13x
52W Range
24.6073% of range37.40
52W High37.40 SEK
52W Low24.60 SEK
Profitability
Gross Margin71.52%
EBITDA Margin14.42%
Profit Margin2.37%
Oper. Margin11.46%
ROE3.01%
ROA2.09%
Revenue Growth-11.90%
Earnings Growth—
Balance Sheet
Debt/Equity0.03
Current Ratio3.10
Quick Ratio2.41
Book Value/Sh10.26 SEK
Cash/Share3.984 SEK
Dividends
Fwd Div Rate0.1000 SEK
Trail. Div Rate0.1000 SEK
Div. Yield0.29%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateMay 8, 2026
Pay Date—
Ownership
Shares Out.32.12M
Float22.15M
Insiders50.36%
Institutions26.99%
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)36.00 SEK
Target Range36.00 SEK – 36.00 SEK
# Analysts1
Company
Market Cap1.12B SEK
Enterprise Value1.03B SEK
Revenue (TTM)427.80M SEK
Gross Profit316.05M SEK
Net Income (TTM)10.46M SEK
Revenue/Share12.65 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees110
Last Price33.90 SEK
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN—